우리나라 의학의 현실과 미래: 교육, 연구, 진료를 중심으로

정대철,Jeong, Dae Chul 연세대학교 의과대학 2019 의학교육논단 Vol.21 No.2

Academic medicine is built from a foundation of education, research, and patient care. Since good patient care results from the application of medical research and continuous education, these three components cannot be separated for medical development to occur. In Korea, many obstacles hinder the achievement of academic medicine, such as an inefficient medical delivery system, limitations of primary care, low insurance prices, and no long-term health care plan. Medical education has changed to outcome-based education, but presented temporal integration status. Governance of healthcare research is not centralized, and Korea is awarded relatively fewer grants than other countries. Medical professors have reached a burnout state due to patient care responsibilities in addition to research and education duties. Many medical systems, including the medical delivery system and insurance problems, may contribute to distrust between doctors and patients. The government is not involved in a long-term health care policy. The multitude of factors mentioned here are hindering the achievement of academic medicine in Korea.

일제하 신문기업의 모형에 관한 시론적 연구

정대철(Dae Chul Jeong) 한양대학교 한국학연구소 1997 韓國學論集 Vol.31 No.-

소아특발관절염의 질병활성도 평가

정대철 ( Dae Chul Jeong ) 대한류마티스학회 2014 대한류마티스학회지 Vol.21 No.6

Juvenile idiopathic arthritis (JIA) is a chronic inflammation of joints in pediatric patients. Assessment of JIA disease activity is very difficult, because children cannot definitely describe their pain by themselves due to development of cognitive function during the pediatric period. Assessment of JIA disease activity is useful for quantitative measurement of patient status, monitoring therapeutic response, and disease course over time. This article reviewed objective assessment tool for JIA disease activity and described differences in assessment between adult rheumatoid arthritis and JIA.

통상환경변화와 지방산업육성의 효율화

정대철(Dae-Chul Jeong) 한국무역학회 2003 貿易學會誌 Vol.28 No.5

한국과 일본 기계산업의 전략적 협력방안 -한,일해협권 기계산업의 협력방안을 중심으로-

정대철 ( Dae Chul Jeong ),양기근 ( Gi Geun Yang ) 한국정책학회 2007 韓國政策學會報 Vol.16 No.3

가솔린 엔진의 공회전 천이구간에서 엔진 제어변수가 배기가스온도 및 배기배출물에 미치는 영향

정대철(Dae-Chul Jeong),박영준(Young-Joon Park),김득상(Duk-Sang Kim),조용석(Yong-Seok Cho) 한국자동차공학회 2006 한국자동차공학회 춘 추계 학술대회 논문집 Vol.- No.-

Increase of an exhaust gas temperature is important strategy which reduces a light off time of three way catalyst at the early stage of the cold start in SI engines. A proper control of engine variables is an effective way to improve emission performance in these cold start operations. This study tried to increase exhaust gas temperature through the controls of engine operating conditions such as spark timing or valve overlap when catalyst heating function is activated. Experiments showed that retarded spark timing and increased valve overlap by virtue of VVT may be helpful to increase exhaust gas temperature. It was also found that the decrease of NOx emission was expected during maintaining combustion stability of the engine with increased valve overlap. This study also showed that sudden changes in ISA and amount of fuel due to the deactivation of catalyst heating function may cause temporal increase of harmful emissions.

마우스 동종 조혈모세포 이식모델에서 Cyclosporin A, FK506, 3-Deazaadenosine 등의 약제가 급성 이식편대 숙주병과 생존에 미치는 영향

진종률,정대철,엄현석,정낙균,박수정,최병옥,민우성,김학기,김춘추,한치화,Jin, Jong Youl,Jeong, Dae Chul,Eom, Hyeon Seok,Chung, Nak Gyun,Park, Soo Jeong,Choi, Byung Ock,Min, Woo Sung,Kim, Hack Ki,Kim, Chun Choo,Han, Chi Wha 대한면역학회 2003 Immune Network Vol.3 No.2

Background: We investigated the effect of donor marrow T cell depletion, administration of FK506, cyclosporin A (CSA), and 3-deazaadenosine (DZA) on graft versus host disease (GVHD) after allogeneic murine hematopoietic stem cell transplantation (HSCT). Methods: We used 4 to 6 week old Balb/c ($H-2^d$, recipient), and C3H/He ($H-2^k$, donor) mice. Total body irradiated recipients received $1{\times}10^7$ bone marrow cells (BM) and $0.5{\times}10^7$ splenocytes of donor under FK506 (36 mg/kg/day), CSA (5 mg/kg/day, 20 mg/kg/day), and DZA (45 mg/kg/day), which were injected intraperitoneally from day 1 to day 14 daily and then three times a week for another 2 weeks. To prevent the GVHD, irradiated Balb/c mice were transplanted with $1{\times}10^7$ rotor-off (R/O) cells of donor BM. The severity of GVHD was assessed daily by clinical scoring method. Results: All experimental groups were well grafted after HSCT. Mice in experimental group showed higher GVHD score and more rapid progression of GVHD than the mice with R/O cells (R/O group) (p<0.01). There were relatively low GVHD scores and slow progressions in FK506 and low dose CSAgroups than high dose CSA group (p<0.01). The survival was better in FK506 group than low dose CSA group. All mice treated with CSA died within 12 days after HSCT. The GVHD score in DZA group was low and slow in comparison with control group (p<0.05), but severity and progression were similar with low dose CSA group (p=0.11). All mice without immunosuppressive treatment died within 8 days, but all survived in R/O group (p<0.01). Survival in low dose CSA group was longer than in control group (p<0.05), but in high dose CSA group, survival was similar to control group. The survival benefit in DZA group was similar with low dose CSA group. FK506 group has the best survival benefit than other groups (p<0.01), comparable with R/O group (p=0.18), although probability of survival was 60%. Conclusion: We developed lethal GVHD model after allogeneic murine HSCT. In this model, immunosuppressive agents showed survival benefits in prevention of GVHD. DZA showed similar survival benefits to low dose CSA. We propose that DZA can be used as a new immunosuppressive agent to prevent GVHD after allogeneic HSCT.

주조직적합항원이 불일치하는 마우스 동종 조혈모세포이식에서 IL-2로 유도된 CD4+CD25+ T세포를 이용한 이식편대숙주병의 억제

현재호,정대철,정낙균,박수정,민우성,김태규,최병옥,김원일,한치화,김학기,Hyun, Jae Ho,Jeong, Dae Chul,Chung, Nak Gyun,Park, Soo Jeong,Min, Woo Sung,Kim, Tai Gyu,Choi, Byung Ock,Kim, Won Il,Han, Chi Wha,Kim, Hack Ki 대한면역학회 2003 Immune Network Vol.3 No.4

Background: In kidney transplantation, donor specific transfusion may induce tolerance as a result of some immune regulatory cells against the graft. In organ transplantation, the immune state arises from a relationship between the immunocompromised graft and the immunocompetent host. However, a reverse immunological situation exists between the graft and the host in hematopoietic stem cell transplantation (HSCT). In addition, early IL-2 injections after an allogeneic murine HSCT have been shown to prevent lethal graft versus host disease (GVHD) due to CD4+ cells. We investigated the induction of the regulatory CD4+CD25+ cells after a transfusion of irradiated recipient cells with IL-2 into a donor. Methods: The splenocytes (SP) were obtained from 6 week-old BALB/c mice ($H-2^d$) and irradiated as a single cell suspension. The donor mice (C3H/He, $H-2^k$) received $5{\times}10^6$ irradiated SP, and 5,000 IU IL-2 injected intraperitoneally on the day prior to HSCT. The CD4+CD25+ cell populations in SP treated C3H/He were analyzed. In order to determine the in vivo effect of CD4+CD25+ cells, the lethally irradiated BALB/c were transplanted with $1{\times}10^7$ donor BM and $5{\times}10^6$ CD4+CD25+ cells. The other recipient mice received either $1{\times}10^7$ donor BM with $5{\times}10^6$ CD4+ CD25- cells or the untreated SP. The survival and GVHD was assessed daily by a clinical scoring system. Results: In the MLR assay, BALB/c SP was used as a stimulator with C3H/He SP, as a responder, with or without treatment. The inhibition of proliferation was $30.0{\pm}13%$ compared to the control. In addition, the MLR with either the CD4+CD25+ or CD4+CD25- cells, which were isolated by MidiMacs, from the C3H/He SP treated with the recipient SP and IL-2 was evaluated. The donor SP treated with the recipient cells and IL-2 contained more CD4+CD25+ cells ($5.4{\pm}1.5%$) than the untreated mice SP ($1.4{\pm}0.3%$)(P<0.01). There was a profound inhibition in the CD4+CD25+ cells ($61.1{\pm}6.1%$), but a marked proliferation in the CD4+CD25- cells ($129.8{\pm}65.2%$). Mice in the CD4+CD25+ group showed low GVHD scores and a slow progression from the post-HSCT day 4 to day 9, but those in the control and CD4+CD25- groups had a high score and rapid progression (P<0.001). The probability of survival was 83.3% in the CD4+CD25+ group until post-HSC day 35 and all mice in the control and CD4+CD25- groups died on post-HSCT day 8 or 9 (P=0.0105). Conclusion: Donor graft engineering with irradiated recipient SP and IL-2 (recipient specific transfusion) can induce abundant regulatory CD4+CD25+ cells to prevent GVHD.

사람의 동종 조혈모세포이식에서 CD4⁺CD25⁺ T세포의 분포와 이식편대숙주병

이대형,정낙균,정대철,조빈,김학기,Lee, Dae Hyoung,Chung, Nak Gyun,Jeong, Dae Chul,Cho, Bin,Kim, Hack Ki 대한소아청소년과학회 2008 Clinical and Experimental Pediatrics (CEP) Vol.51 No.12

목 적: 본 연구의 목적은 사람의 동종 조혈모세포이식에서 공여자의 이식편과 환자의 이식 후 말초혈액에서 $CD4^+CD25^+$ T 세포 분획의 분포를 알아보고 급성 이식편대숙주병(GVHD)과 연관성을 알아보고자 하였다. 방 법: 동종 조혈모세포이식을 시행 받은 17명의 소아를 대상으로 하였다. 공여자의 이식편과 이식 받은 환자의 이식 후 말초혈액으로부터 얻은 검체를 유세포 분석(flow cytometry)하였다. 공여자의 이식편과 이식 후 1개월과 3개월에 환자의 말초혈액 내 $CD4^+CD25^+$ T 세포의 분획과 절대 세포수를 알아보았다. 결 과: 공여자의 이식편 내 $CD4^+CD25^+$ T 세포의 분획은 급성 GVHD 발생군과 비발생군에서 각각 0.90%, 1.06%이었으며 차이가 없었다(P=0.62). 이식편 내 $CD4^+CD25^+$ T세포의 절대수는 급성 GVHD 발생군과 비발생군이 각각 $6.18{\times}10^5/kg$와 $25.85{\times}10^5/kg$으로 급성 GVHD 비발생군이 발생군보다 많은 경향을 보였으나 유의성은 없었다(P=0.09). 급성 GVHD 비발생군의 말초혈액 $CD4^+CD25^+$ T 세포는 이식 후 1개월에 2.11%, 3개월에 1.43%로 유의하게 감소하였으나(P=0.028), 급성 GVHD 발생군의 말초혈액 내 $CD4^+CD25^+$ T 세포는 이식 후 1개월과 3개월에 각각 2.47%와 2.30%로 유의한 차이가 없었다(P=0.50). 결 론: 본 실험을 통하여 저자들은 공여자의 이식편 내 $CD4^+CD25^+$ T세포의 분포와 이식 후 환자의 급성 GVHD의 관계에 대한 유의성은 검증할 수 없었으며 이식 후 환자의 말초혈액 내 $CD4^+CD25^+$ T 세포에는 조절 T세포보다 GVHD와 연관된 활성화된 T세포의 분획이 더 클 것으로 사료되나 추가적인 조절 T세포의 표지자를 이용한 검증이 필요할 것으로 사료된다. Purpose : This study aimed to determine the frequencies of $CD4^+CD25^+$ T cells in donor graft and peripheral blood $CD4^+CD25^+$ T cells in recipients after hematopoietic stem cell transplantation (HSCT) and their association with graft-versus-host disease (GVHD). Methods : Seventeen children who underwent HSCT were investigated. $CD4^+CD25^+$ T cells in samples from donor grafts and recipient peripheral blood were assessed by flow cytometry at 1 and 3 months after transplantation. Results : $CD4^+CD25^+$ T cell frequencies in the grafts showed no significant difference between patients with and without acute GVHD (0.90% vs. 1.06%, P=0.62). Absolute $CD4^+CD25^+$ T cell number in grafts were lower in patients with acute GVHD than in those without acute GVHD ($6.18{\times}10^5/kg$ vs. $25.85{\times}10^5/kg$, P=0.09). Patients without acute GVHD showed a significant decrease in peripheral blood $CD4^+CD25^+$ T cell percentage at 3 months compared to those at 1 month after HSCT (2.11% vs. 1.43%, P=0.028). However, in patients with acute GVHD, $CD4^+CD25^+$ T cell percentage at 3 months was not different from the corresponding percentage at 1 month after HSCT (2.47% vs. 2.30%, P=0.5). Conclusion : The effect of frequencies of $CD4^+CD25^+$ T cells in donor grafts on acute GVHD after HSCT could not be identified, and the majority of peripheral blood $CD4^+CD25^+$ T cells in patients who underwent HSCT may be activated T cells related to acute GVHD rather than regulatory T cells. Further studies with additional markers for regulatory T cells are needed to validate our results.

호산구성 대장염 1례

나주희,박영실,김선미,이정현,정대철,김진택,정승연,이안희,강진한,이준성,Nah, Joo-Hee,Park, Young-Shil,Kim, Sun-Mi,Lee, Jung-Hyun,Jeong, Dae-Chul,Kim, Jin-Tack,Chung, Seung-Yun,Lee, An-Hi,Kang, Jin-Han,Lee, Joon-Sung 대한소아소화기영양학회 2002 Pediatric gastroenterology, hepatology & nutrition Vol.5 No.1

저자들은 설사와 우복부통증 및 체중감소의 증상을 보인 11세 남아에서 말초혈액의 호산구수 증가와 IgE가 정상범위이며 대장내시경하에 채취한 S자결장 생검조직에서 특징적인 호산구침윤 소견이 관찰되어 비 IgE 매개성 호산구성 대장염으로 진단된 1례를 경험하였으며 부신피질 호르몬 투여로 증상 호전을 보여 문헌고찰과 함께 보고하는 바이다. Eosinophilic gastroenteritis, which shows characteristic eosinophilic inflammation, involves any part of the intestine from esophagus to colon. The immunopathogenesis is expected to be associated with IgE-mediated or non-IgE-mediated reaction, but the precise mechanism is not revealed yet. The clinical manifestation is variably dependent on the extent of eosinophilic infiltration. Usually the symptoms, such as abdominal pain, diarrhea, vomiting, wax and wane for a few months result in failure to thrive, which implicates the importance of early detection. Although the diagnosis is made through clinical and histopathologic evidences, we should suspect the illness in a case of anemia, hypoalbuminemia, and peripheral eosinophilia. Recently, we experienced a case of non-IgE-mediated eosinophilic colitis in a 11-year-old male who complained of diarrhea, right lower abdominal pain, body weight loss, was diagnosed with peculiar histopathologic finding of sigmoid colon specimens obtained by sigmoidoscopy.